|Title||Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study.|
|Publication Type||Journal Article|
|Year of Publication||2022|
|Authors||Smith, HStevens, Sanchez, CE, Maag, R, Buentello, A, Murdock, DR, Metcalf, GA, Hadley, TD, Riconda, DL, Boerwinkle, E, Wehrens, XHT, Ballantyne, CM, Gibbs, RA, McGuire, AL, Pereira, S|
|Journal||Circ Genom Precis Med|
|Date Published||2022 Dec|
|Keywords||Cardiology, Cardiovascular Diseases, Clinical Decision-Making, Family, Humans, Surveys and Questionnaires|
BACKGROUND: Routine genome-wide screening for cardiovascular disease risk may inform clinical decision-making. However, little is known about whether clinicians and patients would find such testing useful or acceptable within the context of a genomics-enabled learning health system.
METHODS: We conducted surveys with patients and their clinicians who were participating in the HeartCare Study, a precision cardiology care project that returned results from a next-generation sequencing panel of 158 genes associated with cardiovascular disease risk. Six weeks after return of results, we assessed patients' and clinicians' perceived utility and disutility of HeartCare, the effect of the test on clinical recommendations, and patients' attitudes toward integration of research and clinical care.
RESULTS: Among 666 HeartCare patients with a result returned during the survey study period, 42.0% completed a full or partial survey. Patient-participants who completed a full survey (n=224) generally had positive perceptions of HeartCare independent of whether they received a positive or negative result. Most patient-participants considered genetic testing for cardiovascular disease risk to have more benefit than risk (88.3%) and agreed that it provided information that they wanted to know (81.2%), while most disagreed that the test caused them to feel confused (77.7%) or overwhelmed (78.0%). For 122 of their patients with positive results, clinicians (n=13) reported making changes in clinical care for 66.4% of patients, recommending changes in health behaviors for 36.9% of patients, and recommending to 33.6% of patients that their family members have clinical testing.
CONCLUSIONS: Both patients and clinicians thought the HeartCare panel screen for cardiovascular disease risk provided information that was useful in terms of personal or health benefits to the patient and that informed clinical care without causing patients to be confused or overwhelmed. Further research is needed to assess perceptions of genome-wide screening among the US cardiology clinic population.
|Alternate Journal||Circ Genom Precis Med|
|PubMed Central ID||PMC10163837|
|Grant List||K99 HG011491 / HG / NHGRI NIH HHS / United States|
Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study.
|Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality. Nat Commun. 2023;14(1):6113..|
|PLS3 missense variants affecting the actin-binding domains cause X-linked congenital diaphragmatic hernia and body-wall defects. Am J Hum Genet. 2023;110(10):1787-1803..|
|Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023;14:1188831..|